Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Inovio Pharma (INO)

Inovio Pharma (INO)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 3,391,159
  • Shares Outstanding, K 158,096
  • Annual Sales, $ 4,110 K
  • Annual Income, $ -119,360 K
  • 60-Month Beta 1.47
  • Price/Sales 758.57
  • Price/Cash Flow N/A
  • Price/Book 16.66

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 8 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/20
See More
  • Average Estimate -0.18
  • Number of Estimates 4
  • High Estimate -0.16
  • Low Estimate -0.18
  • Prior Year -0.30
  • Growth Rate Est. (year over year) +40.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
11.13 +92.72%
on 06/08/20
33.79 -36.52%
on 06/26/20
+7.11 (+49.58%)
since 06/02/20
3-Month
6.88 +211.77%
on 04/15/20
33.79 -36.52%
on 06/26/20
+13.93 (+185.24%)
since 04/02/20
52-Week
1.91 +1,020.10%
on 10/02/19
33.79 -36.52%
on 06/26/20
+18.47 (+618.59%)
since 07/02/19

Most Recent Stories

More News
Pharmaceutical Manufacturers and COVID-19 - Manufacturers Focus on Building Production Capacity Alongside Clinical Trials - ResearchAndMarkets.com

ResearchAndMarkets.com published a new article on the pharma industry "Pharmaceutical Manufacturers and COVID-19 - Manufacturers Focus on Building Production Capacity Alongside Clinical Trials"

INO : 21.45 (+8.72%)
Thinking about trading options or stock in FedEx Corp, Inovio Pharmaceuticals, Ford Motor, Boeing, or Plug Power?

, /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for FDX, INO, F, BA, and PLUG.

BA : 180.81 (+0.27%)
FDX : 155.48 (-0.75%)
F : 6.05 (+1.17%)
INO : 21.45 (+8.72%)
Zika Virus Vaccines Market 2027 Growth Opportunities, Top Key Players, Industry Outlook and Forecasts

Worldwide Analysis to 2027 is a specialized and in-depth study of the Zika Virus Vaccines Industry with a focus on the global market trend. The report aims to provide an overview of global Zika Virus...

CERS : 6.76 (unch)
FSCR : 5.0000 (+11.11%)
GSK : 41.22 (+0.88%)
HON : 145.02 (+0.63%)
IMV.TO : 3.87 (-0.51%)
INO : 21.45 (+8.72%)
JGHAF : 17.3000 (unch)
NLNK : 0.8900 (-12.75%)
TKPYY : 16.5900 (-0.90%)
Why Inovio Pharmaceuticals Plunged 20% Today

Shares of biotech company Inovio Pharmaceuticals (INO) fell sharply on Tuesday after announcing updates to its Covid-19 vaccine candidate, INO-4800.

INO : 21.45 (+8.72%)
3 Best Performing Robinhood 100 Stocks for the Quarter

The best three performing stocks in the Robinhood 100 for the last quarter are Ideanomics (IDEX), Workhouse (WKHS), and Inovio (INO). As we just ended the second quarter of 2020, now is a great time...

WKHS : 20.91 (+9.02%)
IDEX : 1.5300 (-11.30%)
INO : 21.45 (+8.72%)
3 Best-Performing Robinhood 100 Stocks in June

Find out what's driving the biggest gaining Robinhood 100 stocks of the past month. Workhorse (WKHS), Nio (NIO), and Inovio (INO) are interesting companies, and investors should keep them on their watchlist....

WKHS : 20.91 (+9.02%)
NIO : 9.38 (+18.58%)
INO : 21.45 (+8.72%)
INOVIO Announces Positive Interim Phase 1 Data For INO-4800 Vaccine for COVID-19

, /PRNewswire/ -- INOVIO (NASDAQ:INO), a biotechnology company focused on rapidly bringing to market precisely designed DNA medicines to protect and treat people from infectious diseases and cancer,...

INO : 21.45 (+8.72%)
3 Top Momentum Stocks for July

DocuSign, Inc. (DOCU), Novavax, Inc. (NVAX), and Inovio Pharmaceuticals, Inc. (INO) are three momentum stocks to keep an eye on in July. Using a momentum investing strategy is one that has proven...

NVAX : 81.64 (+2.43%)
DOCU : 190.99 (+6.72%)
INO : 21.45 (+8.72%)
Moderna Collaborates With Catalent for Coronavirus Vaccine

Moderna (MRNA) teams up with Catalent for large-scale, commercial fill-finish manufacturing of the former's mRNA-based COVID-19 vaccine candidate.

AZN : 53.80 (+0.90%)
MRNA : 58.57 (-4.90%)
INO : 21.45 (+8.72%)
CTLT : 72.74 (-0.86%)
Thinking about trading options or stock in Norwegian Cruise Line, Inovio Pharmaceuticals, VBI Vaccines, Sonos Inc, or Boeing?

, /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for NCLH, INO, VBIV, SONO, and BA.

BA : 180.81 (+0.27%)
INO : 21.45 (+8.72%)
NCLH : 15.97 (-2.74%)
SONO : 15.13 (+2.65%)
VBIV : 2.87 (-2.38%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 96% Buy with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Trade INO with:

Business Summary

Inovio Pharmaceuticals, Inc., formerly known as Inovio Biomedical Corporation, is engaged in the discovery, development, and delivery of a new generation of vaccines, called DNA vaccines, focused on cancers and infectious diseases. The Company's electroporation DNA delivery technology uses brief, controlled...

See More

Key Turning Points

2nd Resistance Point 23.86
1st Resistance Point 22.65
Last Price 21.45
1st Support Level 20.07
2nd Support Level 18.70

See More

52-Week High 33.79
Fibonacci 61.8% 21.61
Last Price 21.45
Fibonacci 50% 17.85
Fibonacci 38.2% 14.09
52-Week Low 1.91

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar